Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04143308
Recruitment Status : Not yet recruiting
First Posted : October 29, 2019
Last Update Posted : October 29, 2019
Sponsor:
Information provided by (Responsible Party):
Kaohsiung Medical University Chung-Ho Memorial Hospital

Brief Summary:
The object is to develop a training system of simultaneous walking and cognitive training for improving cognitive function of people with schizophrenia. The training program, called "Simultaneous Walk And Think for Cognitive Health mobile application software"(SWATCH App), is developed by researchers. A randomized controlled trial will be carried out to test the effectiveness of the training system. Ninety participants will be randomly assigned to: simultaneous training of walking and cognitive group, the cognitive training group, and treatment as usual group. The intervention for those groups will lasts for 12 weeks, with a 12 week of followup. The measurements include the cognitive function, physical fitness, and quality of life.

Condition or disease Intervention/treatment Phase
Schizophrenia Cognitive Function Physical Activity Quality of Life Other: Simultaneous training of walking and cognitive group Other: Cognitive training group Other: Treatment as usual group Not Applicable

Detailed Description:

Background: Schizophrenia is one of the severe mental disorders. In addition to psychiatric symptoms, cognitive impairment is a key clinical feature in this population, which significantly negatively influences their functional performance and independence. While the cognitive remediation therapy demonstrates positive results, it often involves specialized and expensive computerized cognitive training system, which limits its application in clinical setting. More evidence is available to support the benefits of exercise training on cognitive functions of schizophrenia. Combination of exercise and cognitive training is a promising program and can improve cognitive functions of the elderly. However, this combined therapy is still limited to schizophrenia. Simultaneous training of walking and cognitive tasks via auditory mobile application is an innovative program for saving cost, time, and manpower. Further study is needed to develop the simultaneous training program and to examine the effectiveness.

Purposes: To examine the effects of the training program on cognitive functions, fitness, functional performance and quality of life.

Methods: A 3-arm, single-blinded, randomized controlled trial is used to recruit 90 participants and then randomly allocated to the simultaneous training group, the cognitive training group, and the treatment as usual group. The first two training groups receive training for 30-40 minutes, 3 times a week for 12 weeks, as well as a follow-up of 12 weeks. All participants will be assessed at baseline, post-test and follow-up assessment. Primary outcome is cognitive function and secondary outcomes are fitness, functional performance, and quality of life.

Contribution: The study can be used as an evidence-based program to improve cognitive functioning of people with schizophrenia. With the development of mobile App and the use of fitness wearable device, the training program enables people with schizophrenia to walk and practice cognitive training simultaneously in a group format. It will help clinical professionals be able to serve the increasing number of people with severe mental illness with less manpower and specialized equipment. The study is also helpful to better understanding the isolated role of aerobic exercise in the dual-task training, and to apply to other groups, like the elderly or dementia.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: We will conduct a single-blinded, randomized controlled study. Ninety participants will be randomly assigned to: simultaneous training of walking and cognitive group, the cognitive training group, and treatment as usual group.
Masking: Single (Participant)
Primary Purpose: Other
Official Title: The Effects of Simultaneous Training of Walking and Cognitive Tasks on Cognitive Functions of People With Schizophrenia: the Development of Mobile Application System and Effectiveness Analysis
Estimated Study Start Date : November 1, 2019
Estimated Primary Completion Date : July 31, 2021
Estimated Study Completion Date : July 31, 2021

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Schizophrenia

Arm Intervention/treatment
Experimental: Simultaneous training of walking and cognitive group
  1. Wearable technology (fitness wristband & App)
  2. SWATCH system (App & controller)
  3. 3 times a week (30 mins/ each time)
  4. Lasts for 12 weeks
  5. Simultaneous walking and cognitive training
Other: Simultaneous training of walking and cognitive group

Device:

  1. SWATCH system (App & controller)
  2. Wearable technology Fitness wristband & APP

Active Comparator: Cognitive training group
  1. Wearable technology (fitness wristband & App)
  2. SWATCH system (App)
  3. 3 times a week (30 mins/ each time)
  4. Lasts for 12 weeks
  5. Cognitive training while sitting
Other: Cognitive training group

Device:

  1. SWATCH system (App)
  2. Wearable technology Fitness wristband & APP

Active Comparator: Treatment as usual group
1. Keep treatment as usual group at health care system.
Other: Treatment as usual group
Keep treatment as usual




Primary Outcome Measures :
  1. Cognitive function [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]

    MATRICS Consensus Cognitive Battery: Traditional Chinese Version (MCCB) consists of 10 individually administered tests to measure cognitive performance in the following seven domains:

    1. Processing Speed

      1.1 Trail Making Test (TMT).

      1.2 Brief Assessment of Cognition in Schizophrenia: Symbol Coding (BACS SC).

      1.3 Category Fluency: Animal Naming (Fluency).

    2. Attention

      2.1 Continuous Performance Test: Identical Pairs (CPT-IP).

    3. Working memory

      3.1 Wechsler Memory Scale-III (WMS III): Spatial Span.

      3.2 Wechsler Letter: Number Sequencing (WAIS-III).

    4. Verbal Learning

      4.1 Hopkins Verbal Learning Test-Revised (HVLT-R).

    5. Visual Learning

      5.1 Brief Visuospatial Memory Test-Revised (BVMT-R).

    6. Reasoning and Problem Solving

      6.1 Neuropsychological Assessment Battery (NAB): Mazes.

    7. Social Cognition

    7.1 Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT): Managing Emotions.



Secondary Outcome Measures :
  1. Body composition [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    Using Body Mass Index (BMI) as the measurement of body composition, which weight and height will be combined to report BMI in kg/m^2.

  2. Cardiorespiratory fitness [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    Using 6-minute walk test (6MWT) as the measurement, which let the participant walks as far as possible over a total of six minutes on hard and flat floor. And the researcher will measure the distance that participant walks in 6 minutes.

  3. Leg muscular strength and endurance [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    Using 30-Second Sit to Stand Test. The participant will sit in the middle of the chair, and rise to a full standing position, then sit back down again. Repeat these movements for 30 seconds. And researcher will count the times.

  4. Balance and Agility [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    The Timed Up and Go test (TUG). It measures the time that the participant takes to rise from a chair, walk eight foots, turn around, walk back to the chair, and sit down.

  5. Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    Dual-Task Performance Involving Hand Dexterity and Cognitive Tasks, this test is combine the Purdue Pegboard Test (PPT; Tiffin & Asher, 1948) and the Serial Sevens Subtraction Test (SSST; Manning, 1982), Purdue Pegboard Test use to measures hand dexterity; Serial Sevens Subtraction Test as a cognitive task for the dual-task condition.

  6. Instrumental Activity of Daily Living (IADL) [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    Lawton and Brody Instrumental Activity of Daily Living Scale is a self-report survey. It is used to evaluate the degree of participant's instrumental activities. There are total 8 descriptions, the scale scores ranges is between 0 to 8. The higher values represent a better outcome.

  7. Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) [ Time Frame: Change from baseline outcome measure at 12th week (post-test), and at 24th week (follow-up test) ]
    Schizophrenia Quality of Life Scale Revision 4 is a self-report survey. It is used to evaluate the degree of participant's quality of life. There are total 33 items, the scale scores statements are rated 1 (never) to 5 (always). The higher values represent a better outcome.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Diagnosis of schizophrenia or schizoaffective disorder by a psychiatric clinician on the basis of the criteria set the Diagnostic and Statistical Manual of Mental Disorders 5th edition, DSM-5, has been more than 1 year.
  2. Age 20-60 years old.
  3. Living in daycare center or community-based mental health rehabilitation services or rehabilitation ward.
  4. Having stable psychiatric conditions (i.e., primary psychiatric medications had not changed for more than two months)
  5. The MATRICS Consensus Cognitive Battery (MCCB) (Nuechterlein et al., 2008) shows that at least one domain with cognitive impairment (below the value of -1SD).
  6. Can follow the research process and sign the consent form.

Exclusion Criteria:

  1. Traumatic brain injury and other neurological diseases, alcohol and substance abuse
  2. Pregnancy, cardiovascular disease, and unsuitable to exercise training due to physical movement difficulties
  3. According participants' self-report, having following conditions, including severe heart failure, myocardial infarction, angina pectoris, chronic obstructive pulmonary disease, COPD, poor glycemic control (i.e., dialysis, diabetic neuropathy or retinopathy) and lower extremity arthritis
  4. Uncontrolled hypertension with SBP> 160 mmHg or DBP> 110 mmHg
  5. Diagnosis of intellectual disability
  6. Unconscious or confusion of consciousness
  7. Participating in other intervention studies

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04143308


Contacts
Layout table for location contacts
Contact: Ming-De Chen, Ph.D. +886988202035 mchen37@gmail.com

Locations
Layout table for location information
Taiwan
Ming-De Chen Recruiting
Kaohsiung, Taiwan
Sponsors and Collaborators
Kaohsiung Medical University Chung-Ho Memorial Hospital
Investigators
Layout table for investigator information
Principal Investigator: Ming-De Chen, Ph.D. Department of Occupational Therapy, College of Health Sciences, Kaohsiung Medical University

Layout table for additonal information
Responsible Party: Kaohsiung Medical University Chung-Ho Memorial Hospital
ClinicalTrials.gov Identifier: NCT04143308     History of Changes
Other Study ID Numbers: KMUHIRB-SV(I)-20170080
First Posted: October 29, 2019    Key Record Dates
Last Update Posted: October 29, 2019
Last Verified: August 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
Schizophrenia
Cognitive functional training
Dual-task training
Aerobic exercise
Mobile application
Additional relevant MeSH terms:
Layout table for MeSH terms
Schizophrenia
Schizophrenia Spectrum and Other Psychotic Disorders
Mental Disorders